Effectiveness of biologic DMARDs in monotherapy versus in combination with synthetic DMARDs in rheumatoid arthritis: data from the Swiss Clinical Quality Management Registry - Concepedia

Concepedia

Publication | Closed Access

Effectiveness of biologic DMARDs in monotherapy versus in combination with synthetic DMARDs in rheumatoid arthritis: data from the Swiss Clinical Quality Management Registry

94

Citations

25

References

2015

Year

Cem Gabay, Myriam Riek, Almut Scherer, Axel Finckh

Abstract

Our data suggest that bDMARD monotherapy is prescribed to more complex cases and is significantly less effective than bDMARD therapy in combination with sDMARDs, but to an extent that is clinically only marginally relevant.

References

	Year	Citations
Statistical Analysis With Missing Data Maureen Lahiff, Roderick J. A. Little, Donald B. Rubin Journal of the American Statistical Association EngineeringEstimation StatisticData PreparationData TreatmentBiostatistics	1989	17.5K
Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis Jonathan Edwards, L Szczepański, Jacek Szechiński, New England Journal of Medicine	2004	2.6K
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update Josef S Smolen, Robert Landewé, Ferdinand C. Breedveld, Annals of the Rheumatic Diseases	2013	1.8K
Multiple Imputation for Missing Data Paul D. Allison Sociological Methods & Research Bootstrap ResamplingEngineeringData ScienceIncompletenessEstimation Statistic	2000	789
Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study Graeme Jones, Anthony Sebba, Jianhui Gu, Annals of the Rheumatic Diseases	2009	789
Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab Jun Hashimoto, N. Miyasaka, Kazuhiko Yamamoto, Annals of the Rheumatic Diseases	2007	739
Bias and efficiency of multiple imputation compared with complete‐case analysis for missing covariate values Ian R. White, John B. Carlin Statistics in Medicine	2010	734
Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial Cem Gabay, Paul Emery, Ronald van Vollenhoven, The Lancet Rheumatoid DisorderRheumatologyAutoimmune DiseaseAllergyPhase 4	2013	664
Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy Norihiro Nishimoto, Nobuyuki Miyasaka, Kazuhiko Yamamoto, Modern Rheumatology ImmunologyPharmacotherapyDose MtxImmunotherapyPsoriatic Arthritis	2008	335
Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists Johan Askling, C. Michael Fored, L. Brandt, Annals of the Rheumatic Diseases	2007	334

Page 1